MedTrace Logo

A Sunscreen Based on Bioadhesive Nanoparticles

NCT02668536 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2018-03-13

No results posted yet for this study

Summary

The initial focus of the study will be on safety, sun protection factor (SPF) characterization, and substantivity (duration of protection) studies. The primary outcome of the study will be to measure the sun protection factor (SPF) of a bioadhesive nanoparticles (BNP) formulation in 20-25 healthy volunteers with fair skin.

Conditions

Interventions

DRUG

Standard Sunscreen

Areas will be treated with a standard preparation, consisting of padimate O (7%) and oxybenzone (3%) will be used as the control sunscreen.

DEVICE

BNP

Additional areas will be treated with empty bioadhesive nanoparticles (BNPs).

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Michael Girardi, MD, FAAD · Yale University

  • Mark Saltzman, PhD · Yale University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-17
Primary Completion
2017-08-18
Completion
2017-08-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02668536 on ClinicalTrials.gov